ICICI Bank's fundamental outlook is anchored by robust fee income expansion, with non-interest income surging to $350.2B in 2026Q4 (41.4% of revenue), driving net income to $147.6B. However, the bank's reliance on volatile fee streams and dramatic swings in lo...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Net interest income grew 8.7% YoY to $275.5B in 2026Q4, but the efficiency ratio deteriorated to 49.0% as fee income surged to a record $350.2B, representing 41.4% of total revenue.
IBM’s generative AI business has surpassed $12.5 billion in revenue, underscoring strong enterprise adoption of its watsonx platform. The company’s deep integration into critical IT systems worldwide positions it to scale new AI solutions, and the 2025 acquisition of HashiCorp will further strengthen its cloud automation capabilities.
In Q4 2025, IBM reported a 12.2% year‑over‑year revenue increase to $19.69 billion, while net income surged 92.2%. Full‑year 2025 revenue rose 7.62% to $67.54 billion, with earnings up 75.88%. Analysts project revenue to reach $71.89 billion this year and $75.19 billion next year, with EPS expected to rise 12.10% and 8.23% respectively.
Software remains IBM’s highest‑margin segment, contributing over $30 billion annually, driven by Red Hat and watsonx. The consulting business also experienced growth, reinforcing IBM’s position in high‑margin services.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 20, 2026 | $0.43+4.4% vs $0.41 | $3.4B+0.7% vs $3.4B |
Q3 2026 Jul 18, 2026 | $0.43+7.5% vs $0.40 | $3.4B+3.0% vs $3.3B |
Q2 2026 Apr 18, 2026 | $0.41+5.1% vs $0.39 | $3.1B-4.6% vs $3.3B |
Q1 2026 Jan 17, 2026 | $0.35-7.9% vs $0.38 | $3.2B-3.5% vs $3.3B |
AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.
AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
Disseminated on behalf of Onco-Innovations Ltd. , may include paid advertisements.
AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
Benchmark IBN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for ICICI Bank Limited (IBN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $27.91 | $101.13B | 17.88 | 8.53% | 17.37% | 15.31% | 0.81% | |
| $22.79 | $116.9B | 4.69 | 37.53% | 15.36% | 17.76% | — | |
| $8.18 | $90.16B | 10.78 | 4.21% | 12.29% | 21.05% | — | |
| $3.46 | $36.59B | 8.19 | 44.49% | 15.21% | 13.29% | — | |
| $125.39 | $44.03B | 11.27 | 87.09% | 53.7% | 10.57% | — | |
| $79.83 | $37.73B | 11.18 | 3.42% | 27.68% | 8.82% | — |
ICICI Bank Limited (IBN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when IBN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ICICI Bank Limited (IBN) stock FAQ — growth, dividends, profitability & financials explained
ICICI Bank Limited (IBN) grew revenue by 8.5% over the past year. This is steady growth.
Yes, ICICI Bank Limited (IBN) is profitable, generating $543.12B in net income for fiscal year 2026 (17.4% net margin).
Yes, ICICI Bank Limited (IBN) pays a dividend with a yield of 0.81%. This makes it attractive for income-focused investors.
ICICI Bank Limited (IBN) has a return on equity (ROE) of 15.3%. This is reasonable for most industries.
ICICI Bank Limited (IBN) has a net interest margin (NIM) of 3.6%. This indicates healthy earnings from lending activities.
ICICI Bank Limited (IBN) has an efficiency ratio of 44.9%. This is excellent, indicating strong cost control.
